Medicare Program; Request for Information on Hospital and Vendor Readiness for Electronic Health Records Hospital Inpatient Quality Data Reporting; Extension of Comment Period, 4151-4152 [2013-01142]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with
Federal Register / Vol. 78, No. 13 / Friday, January 18, 2013 / Notices
(NIOSH) of the Centers for Disease
Control and Prevention (CDC) has
pioneered research on the toxicological
properties and characteristics of
nanoparticles. This research has
involved characterizing occupationally
relevant nanoparticles for predicting
whether these particles pose a risk of
adverse health effects and for providing
guidance on controlling workplace
exposures. In September 2005, NIOSH
developed a strategic plan to further
guide the Institute in identifying and
prioritizing nanotechnology research. In
2009 this strategic plan [https://
www.cdc.gov/niosh/docs/2010-105] was
updated based on knowledge gained
from results of ongoing NIOSH research
[see Progress Toward Safe
Nanotechnology in the Workplace; A
Report from the NIOSH Nanotechnology
Research Center https://www.cdc.gov/
niosh/docs/2007-123/] and from the
public and stakeholder input. NIOSH
would like to build on the
accomplishments of ongoing research
[https://www.cdc.gov/niosh/docs/2013101/ and https://www.cdc.gov/niosh/
docs/2010-104/] to develop strategic
research goals and objectives for
nanotechnology occupational safety and
health research through 2016. NIOSH
has identified 10 critical research areas
for nanotechnology research and
communication. These 10 critical
research areas are (1) Toxicity and
internal dose, (2) measurement
methods, (3) exposure assessment, (4)
epidemiology and surveillance, (5) risk
assessment, (6) engineering controls and
personal protective equipment (PPE), (7)
fire and explosion safety, (8)
recommendations and guidance, (9)
global collaborations, and (10)
applications.
NIOSH is considering focusing the
overarching strategic research goals for
these critical areas on 5 key objectives:
(1) Increase understanding of new
hazards and related health risks to
nanomaterial workers; (2) Expand
understanding of the initial hazard
findings on engineered nanomaterials;
(3) Support the creation of guidance
materials to inform nanomaterial
workers, employers, health
professionals, regulatory agencies, and
decision-makers about hazards, risks,
and risk management approaches; (4)
Support epidemiologic studies for
nanomaterial workers, including
medical and exposure studies; and 5)
Assess and promote national adherence
with risk management guidance.
NIOSH requests public input to
address the following:
(1) What is the basis or rationale for
priorities that NIOSH should give for
studies of toxicity evaluation and/or
VerDate Mar<15>2010
16:52 Jan 17, 2013
Jkt 229001
workplace exposure characterization for
engineered nanoparticles?
(2) What rationale can be provided for
recommending needs and types of
technical and educational guidance
materials?
Dated: January 14, 2013.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2013–00994 Filed 1–17–13; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3278–N]
Medicare Program; Request for
Information on Hospital and Vendor
Readiness for Electronic Health
Records Hospital Inpatient Quality
Data Reporting; Extension of Comment
Period
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Request for information;
extension of the comment period.
AGENCY:
This notice extends the
comment period for a request for
information (RFI) which was published
in the January 3, 2013 Federal Register
(78 FR 308). The RFI requests that
hospitals, electronic health record (EHR)
vendors, and other interested parties
respond to questions regarding their
readiness to conduct electronic
reporting of certain patient-level data
under the Hospital Inpatient Quality
Reporting (IQR) Program using the
Quality Reporting Document
Architecture (QRDA) Category I. The
comment period for the RFI, which
would have ended on January 22, 2013,
is extended to February 1, 2013.
DATES: The comment period for the
request for information published in the
January 3, 2013 Federal Register (78 FR
308) is extended to February 1, 2013.
ADDRESSES: In commenting, please refer
to file code CMS–3278–NC. Because of
staff and resource limitations, we cannot
accept comments by facsimile (FAX)
transmission.
You may submit comments in one of
four ways (please choose only one of the
ways listed):
1. Electronically. You may submit
electronic comments on this regulation
to https://www.regulations.gov. Follow
the instructions under the ‘‘More Search
Options’’ tab.
SUMMARY:
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
4151
2. By regular mail. You may mail
written comments to the following
address ONLY: Centers for Medicare &
Medicaid Services, Department of
Health and Human Services, Attention:
CMS–3278–NC, P.O. Box 8013,
Baltimore, MD 21244–8013.
Please allow sufficient time for mailed
comments to be received before the
close of the comment period.
3. By express or overnight mail. You
may send written comments to the
following address ONLY: Centers for
Medicare & Medicaid Services,
Department of Health and Human
Services, Attention: CMS–3278–NC,
Mail Stop C4–26–05, 7500 Security
Boulevard, Baltimore, MD 21244–1850.
4. By hand or courier. If you prefer,
you may deliver (by hand or courier)
your written comments before the close
of the comment period to either of the
following addresses:
a. For delivery in Washington, DC—
Centers for Medicare & Medicaid
Services, Department of Health and
Human Services, Room 445–G, Hubert
H. Humphrey Building, 200
Independence Avenue, SW.,
Washington, DC 20201.
(Because access to the interior of the
Hubert H. Humphrey Building is not
readily available to persons without
Federal government identification,
commenters are encouraged to leave
their comments in the CMS drop slots
located in the main lobby of the
building. A stamp-in clock is available
for persons wishing to retain a proof of
filing by stamping in and retaining an
extra copy of the comments being filed.)
b. For delivery in Baltimore, MD—
Centers for Medicare & Medicaid
Services, Department of Health and
Human Services, 7500 Security
Boulevard, Baltimore, MD 21244–1850.
If you intend to deliver your
comments to the Baltimore address,
please call telephone number (410) 786–
9994 in advance to schedule your
arrival with one of our staff members.
Comments mailed to the addresses
indicated as appropriate for hand or
courier delivery may be delayed and
received after the comment period.
Submission of comments on
paperwork requirements. You may
submit comments on this document’s
paperwork requirements by following
the instructions at the end of the
‘‘Collection of Information
Requirements’’ section in this
document.
For information on viewing public
comments, see the beginning of the
SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT:
Maria Harr, (410) 789–6710.
E:\FR\FM\18JAN1.SGM
18JAN1
4152
Federal Register / Vol. 78, No. 13 / Friday, January 18, 2013 / Notices
In the
January 3, 2013 Federal Register (78 FR
308), we published a document
requesting information from hospitals,
electronic health record (EHR) vendors,
and other interested parties regarding
hospital readiness to begin
electronically reporting certain patientlevel data under the Hospital Inpatient
Quality Reporting (IQR) Program using
the Quality Reporting Document
Architecture (QRDA) Category I
beginning with calendar year 2014
discharges.
Because of the scope of the requested
information and inquiries received from
several industry and professional
organizations/associations regarding the
need for additional time to respond to
our request, we are extending the
comment period until February 1, 2013.
SUPPLEMENTARY INFORMATION:
Dated: January 15, 2013.
Marilyn Tavenner,
Acting Administrator, Centers for Medicare
& Medicaid Services.
[FR Doc. 2013–01142 Filed 1–16–13; 4:15 pm]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–0333]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Recordkeeping
Requirements for Microbiological
Testing and Corrective Measures for
Bottled Water
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice invites comments on
the procedure by which both domestic
and foreign bottled water manufacturers
mstockstill on DSK4VPTVN1PROD with
SUMMARY:
VerDate Mar<15>2010
16:52 Jan 17, 2013
Jkt 229001
that sell bottled water in the United
States maintain records of
microbiological testing and corrective
measures, in addition to existing
recordkeeping requirements.
DATES: Submit either electronic or
written comments on the collection of
information by March 19, 2013.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
Domini Bean, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400T, Rockville, MD 20850,
domini.bean@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Recordkeeping Requirements for
Microbiological Testing and Corrective
Measures for Bottled Water—21 CFR
129.35(a)(3)(i), 129.80(g), and 129.80(h)
(OMB Control Number 0910–0658)—
Extension
The bottled water regulations in parts
129 and 165 (21 CFR parts 129 and 165)
require that if any coliform organisms
are detected in weekly total coliform
testing of finished bottled water,
followup testing must be conducted to
determine whether any of the coliform
organisms are Escherichia coli. The
adulteration provision of the bottled
water standard (§ 165.110(d)) provides
that a finished product that tests
positive for E. coli will be deemed
adulterated under section 402(a)(3) of
the Federal Food, Drug, and Cosmetic
Act (21 U.S.C. 342(a)(3)). In addition,
the current good manufacturing practice
(CGMP) regulations for bottled water in
part 129 require that source water from
other than a public water system (PWS)
be tested at least weekly for total
coliform. If any coliform organisms are
detected in the source water, the bottled
water manufacturers are required to
determine whether any of the coliform
organisms are E. coli. Source water
found to contain E. coli is not
considered water of a safe, sanitary
quality and would be unsuitable for
bottled water production. Before a
bottler may use source water from a
source that has tested positive for E.
coli, a bottler must take appropriate
measures to rectify or otherwise
eliminate the cause of the
contamination. A source previously
found to contain E. coli will be
considered negative for E. coli after five
samples collected over a 24-hour period
from the same sampling site are tested
and found to be E. coli negative.
Description of Respondents: The
respondents to this information
collection are domestic and foreign
bottled water manufacturers that sell
bottled water in the United States.
FDA estimates the burden of this
collection of information as follows:
E:\FR\FM\18JAN1.SGM
18JAN1
]]>Agencies
[Federal Register Volume 78, Number 13 (Friday, January 18, 2013)]
[Notices]
[Pages 4151-4152]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-01142]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3278-N]
Medicare Program; Request for Information on Hospital and Vendor
Readiness for Electronic Health Records Hospital Inpatient Quality Data
Reporting; Extension of Comment Period
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Request for information; extension of the comment period.
-----------------------------------------------------------------------
SUMMARY: This notice extends the comment period for a request for
information (RFI) which was published in the January 3, 2013 Federal
Register (78 FR 308). The RFI requests that hospitals, electronic
health record (EHR) vendors, and other interested parties respond to
questions regarding their readiness to conduct electronic reporting of
certain patient-level data under the Hospital Inpatient Quality
Reporting (IQR) Program using the Quality Reporting Document
Architecture (QRDA) Category I. The comment period for the RFI, which
would have ended on January 22, 2013, is extended to February 1, 2013.
DATES: The comment period for the request for information published in
the January 3, 2013 Federal Register (78 FR 308) is extended to
February 1, 2013.
ADDRESSES: In commenting, please refer to file code CMS-3278-NC.
Because of staff and resource limitations, we cannot accept comments by
facsimile (FAX) transmission.
You may submit comments in one of four ways (please choose only one
of the ways listed):
1. Electronically. You may submit electronic comments on this
regulation to https://www.regulations.gov. Follow the instructions under
the ``More Search Options'' tab.
2. By regular mail. You may mail written comments to the following
address ONLY: Centers for Medicare & Medicaid Services, Department of
Health and Human Services, Attention: CMS-3278-NC, P.O. Box 8013,
Baltimore, MD 21244-8013.
Please allow sufficient time for mailed comments to be received
before the close of the comment period.
3. By express or overnight mail. You may send written comments to
the following address ONLY: Centers for Medicare & Medicaid Services,
Department of Health and Human Services, Attention: CMS-3278-NC, Mail
Stop C4-26-05, 7500 Security Boulevard, Baltimore, MD 21244-1850.
4. By hand or courier. If you prefer, you may deliver (by hand or
courier) your written comments before the close of the comment period
to either of the following addresses:
a. For delivery in Washington, DC--Centers for Medicare & Medicaid
Services, Department of Health and Human Services, Room 445-G, Hubert
H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC
20201.
(Because access to the interior of the Hubert H. Humphrey Building
is not readily available to persons without Federal government
identification, commenters are encouraged to leave their comments in
the CMS drop slots located in the main lobby of the building. A stamp-
in clock is available for persons wishing to retain a proof of filing
by stamping in and retaining an extra copy of the comments being
filed.)
b. For delivery in Baltimore, MD--Centers for Medicare & Medicaid
Services, Department of Health and Human Services, 7500 Security
Boulevard, Baltimore, MD 21244-1850.
If you intend to deliver your comments to the Baltimore address,
please call telephone number (410) 786-9994 in advance to schedule your
arrival with one of our staff members.
Comments mailed to the addresses indicated as appropriate for hand
or courier delivery may be delayed and received after the comment
period.
Submission of comments on paperwork requirements. You may submit
comments on this document's paperwork requirements by following the
instructions at the end of the ``Collection of Information
Requirements'' section in this document.
For information on viewing public comments, see the beginning of
the SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT: Maria Harr, (410) 789-6710.
[[Page 4152]]
SUPPLEMENTARY INFORMATION: In the January 3, 2013 Federal Register (78
FR 308), we published a document requesting information from hospitals,
electronic health record (EHR) vendors, and other interested parties
regarding hospital readiness to begin electronically reporting certain
patient-level data under the Hospital Inpatient Quality Reporting (IQR)
Program using the Quality Reporting Document Architecture (QRDA)
Category I beginning with calendar year 2014 discharges.
Because of the scope of the requested information and inquiries
received from several industry and professional organizations/
associations regarding the need for additional time to respond to our
request, we are extending the comment period until February 1, 2013.
Dated: January 15, 2013.
Marilyn Tavenner,
Acting Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 2013-01142 Filed 1-16-13; 4:15 pm]
BILLING CODE 4120-01-P
